Last updated 2026-07-20
- Acquired by Psych Capital Plc for $4.4M, Jun 2023
- Raised $510k SAFE, Jun 2023
Total raised
$510K
Stage
Pre-Funding
Founded
2021
Headcount
3
HQ
Ramat HaSharon, Israel
Sector
Health Tech & Life Sciences
About
Short Wave Pharma is an Israeli-based biopharmaceutical company focused on developing novel formulations of psilocybin and additional APIs, as well as customized delivery methods, to provide therapeutic benefits for patients suffering from mental health disorders, with an initial focus on eating disorders. The company is conducting pre-clinical studies related to its anorexia nervosa product, which combines a novel formulation and a buccal film delivery system. Shortwave's leadership team has extensive experience in drug development, clinical research, accelerated regulatory pathways, and the pharmaceutical industry.
Funding history · 1 round · $510K total
2023-06
SAFE
$510K
Euroland.Com, June 2023
Headcount over time
From 4 (2022-08) to 3 (2025-01) · -1 (-25%) · 6 points · source: Finder history + radar grounding
Q&A
- What is Short Wave Pharma's primary focus?
- Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, and chronic pain.
- Where is Short Wave Pharma headquartered?
- Short Wave Pharma is headquartered in Ramat HaSharon, Israel.
- When was Short Wave Pharma founded?
- Short Wave Pharma was founded in January 2021.
- What is the current employee count for Short Wave Pharma?
- Short Wave Pharma has 1-10 employees.
- What is Short Wave Pharma's current funding stage?
- Short Wave Pharma is currently in the Pre-Funding stage.
- What preclinical studies has Short Wave Pharma begun?
- Short Wave Pharma has begun preclinical studies related to its product for anorexia nervosa.
- What are Short Wave Pharma's future program plans?
- Short Wave Pharma's future programs include the development of novel formulations and delivery approaches for chronic pain and neurodegenerative diseases.
- What is Short Wave Pharma's primary sector?
- Short Wave Pharma's primary sector is Health Tech & Life Sciences.
Team · 5
Rivki Stern Youdkevich
Founder · Co-founder & CEO
Nadya Lisovoder
Founder · Co-founder & CRO
Jesse Kaplan
Founder · Co-founder
Sruli Weinreb
Founder · Co-founder
Stephen Murphy
Founder · Co-Founder & Executive director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2CB2BB2G
Tags
mental-healthpharmaceuticalspatent-pendingdrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | tomahawkmetals.com |
|---|---|
| linkedin.com/company/80547283 |
Identifiers & details
| Legal name | Short Wave Pharma Inc. |
|---|---|
| Founded | 2021-1 |
| Employees (exact) | 3 |
| Offices | Toronto; Toronto |
Acquisitions & public offerings
Acquired by Psych Capital Plc 2023-06 $4.4M
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | tomahawkmetals.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|